President Donald Trump signed an executive order on Monday formally designating the street drug fentanyl as a “weapon of mass destruction,” saying the manufacture and distribution of the substance — largely carried out by organized criminal networks — threatens national security and fuels lawlessness at home and in the hemisphere. Speaking in the Oval Office, Trump said fentanyl has caused carnage in American families “worse than U.S. deaths in many wars” and claimed “two to three hundred thousand people die every year” from it.
Those figures are far higher than federal data. A Centers for Disease Control and Prevention report shows roughly 48,000 U.S. deaths last year involved fentanyl, a decline of about 27 percent from the prior year. Drug policy and weapons experts also say fentanyl is a poor fit for a weapon-of-mass-destruction label: only one documented incident — the 2002 Russian use of a fentanyl derivative in gas form — has shown how it might be weaponized, and there are no reported U.S. cases. A 2019 study by the National Defense University’s Center for the Study of Weapons of Mass Destruction concluded there was no clear basis or net benefit to such a designation.
Public-health specialists emphasize that U.S. overdose deaths are driven mainly by widespread opioid addiction and the presence of illicitly manufactured fentanyl in the drug supply, not by cartels deliberately using fentanyl as a weapon. Jeffrey Singer, a physician and drug expert at the Cato Institute, said smugglers are meeting market demand rather than waging war on the U.S. “I don’t know how you can equate smugglers meeting market demand and selling something illegal to someone who wants to buy it as an act of war,” he said. Most drug-policy analysts predict the WMD designation will do little to curb street supply or reduce overdose fatalities.
The executive order is part of a broader shift toward militarized responses in the administration’s drug strategy, which has included reclassifying cartels as terrorist organizations and ordering military strikes on suspected drug-running boats. An NPR analysis found the U.S. military has carried out at least 22 strikes on suspected drug vessels in the Caribbean and eastern Pacific this year, killing more than 80 people. Trump has defended the campaign, saying at a recent event that “every boat that gets hit, we save 25,000 American lives.”
Scholars who study trafficking and addiction dispute both the strikes’ likely effectiveness and the arithmetic. Vanda Felbab-Brown of the Brookings Institution said killing individual drug couriers or attacking boats has minimal effect on overall drug flows or cartel systems. She noted that fentanyl — which now accounts for the majority of U.S. drug deaths — largely originates and is trafficked through different channels than the cocaine shipments often moved through the Caribbean, meaning strikes in those waters are unlikely to affect fentanyl supply. Cocaine, not fentanyl, predominates in Caribbean trafficking and accounted for roughly 22,000 U.S. deaths in 2024, according to provisional CDC data.
Critics warn the use of military force may produce unintended consequences. Singer argued that pressure on certain trafficking routes can push criminal groups to produce and ship more potent synthetic drugs — fentanyl, methamphetamines, nitazenes — that are easier to produce and smuggle and more lethal. The administration’s 2025 national security strategy elevated countering “narco-terrorists” as a Defense Department priority and called for the use of lethal force to replace a law enforcement–only approach.
Opponents also point to what they see as inconsistent policy signals from the president. Observers say a string of high-profile pardons and releases undercut claims of a steady, principled counter-narcotics policy. Since returning to the White House, Trump has pardoned or commuted sentences for figures including the former leader of the Gangster Disciples gang, the creator of the Silk Road website, and most controversially, former Honduran president Juan Orlando Hernández, who had been convicted in U.S. court on drug trafficking and weapons charges. Trump’s pardon of Hernández prompted rebukes from Democrats such as Sen. Tim Kaine, who called it “shocking” given Hernández’s conviction as a leader of a major criminal enterprise. The administration also returned key MS-13 informants to El Salvador and, during Trump’s first term, released Mexican Gen. Salvador Cienfuegos Zepeda from U.S. custody and dropped charges despite evidence tying him to a deadly cartel.
Felbab-Brown said such pardons and reversals raise questions about the administration’s overall aims. “There is no steady principled focus on counter-narcotics policy,” she said, though she added that Trump’s hardline posture has pressured some foreign governments — including Mexico’s administration under President Claudia Sheinbaum — to step up counter-narcotics measures, partly in response to the threat of tariffs and cartel designations.
Some conservative analysts support the administration’s tougher stance. Andrés Martínez-Fernández of the Heritage Foundation said drastic actions, including military measures and terrorist designations for cartels, were overdue and could be necessary to confront the threat. He conceded concerns about selective pardons are reasonable but argued targeted clemency, combined with military and diplomatic pressure, might improve cooperation from regional partners.
The White House and administration officials remain convinced the militarized approach will reduce drug deaths. A White House spokeswoman said any vessel bringing “deadly poison” to U.S. shores poses a threat that justifies force. Attorney General Pam Bondi during an early cabinet briefing claimed drug seizures in the administration’s first 100 days had already “saved … 258 million American lives,” a hyperbolic remark described by researchers as wildly exaggerated. Vice President J.D. Vance has defended lethal action against cartel members as a key use of military power.
Nevertheless, many experts warn that labeling fentanyl a WMD and expanding kinetic operations against trafficking networks are unlikely to address the root causes of overdose mortality. They contend effective reduction of deaths will require public-health approaches to addiction, improved treatment access, harm reduction measures, and international cooperation focused on production and distribution networks tailored to the realities of synthetic opioid markets rather than simply increasing military pressure.